FDA: Johnson & Johnson’s Single-Shot COVID-19 Vaccine has ‘Favorable Safety Profile’
on February 24, 2021
24 Comments
The FDA staff has endorsed the Johnson & Johnson single-shot COVID-19 vaccine for emergency use after a trial on 44,000 patients.
If approved, the market will have three COVID-19 vaccines.





